The mean platelet volume in patients with essential and white coat hypertension

References

• Benzaquen LR, Yu H, Rifai N. High sensitivity C-reactive protein: An emerging role in cardiovascular risk assessment. Crit Rev Clin Lab Sci 2002;39:459–497.
   PubMed Web of Science ®Google Scholar
• Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: Is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9:177–190.
   PubMed Web of Science ®Google Scholar
• Broadley AJ, Gapper P, Schmitt M, Frenneaux MP. Supine rest reduces platelet activation and aggregation. Platelets 2003;14:3–7.
   PubMed Web of Science ®Google Scholar
• Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets 2002;13:301–306.
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157–161.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Mezzetti A, Lapenna D, Guglielmi MD, Mancini M, Salvatore L, Antidormi T, Costantini F, Cuccurullo F. White-coat hypertension in patients with newly diagnosed hypertension: Evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J 1995;16:692–697.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Bucci A, Costantini F, Lapenna D, Cuccurullo F, Mezzetti A. Twenty-four-hour autonomic nervous function in sustained and ‘‘white coat’’ hypertension. Am Heart J. 2000;140:672–677.
   PubMed Web of Science ®Google Scholar
• Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coar hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995;26:413–419.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793–801.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Bucci A, Lapenna D, Lattanzio FM, Talone L, Cuccurullo F, Mezzetti A. Circulating homocys- teine levels in sustained and white coat hypertension. J Hum Hypertens 2003;17:165–170.
   PubMed Web of Science ®Google Scholar
• Coban E, Ozdogan M. The plasma levels of plasminogen activator inhibitor-1 in subjects with white coat hypertension. Int J Clin Pract 2004;58:541–544.
   PubMed Web of Science ®Google Scholar
• White WB, Schulman P, Mc Cabe EJ, Day HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. J Am Med Assoc 1989;261:873–877.
   PubMed Web of Science ®Google Scholar
• Zakopoulos N, Papamichael C, Papaconstantinou H., Dubbins PA, Burrell CJ, Lekakis J, Stamatelopoulos S, Moulopoulos S. Isolated clinic hypertension is not an innocent phenomenon: Effect on the carotid artery structure. American Journal of Hypertension: Am J Hypertens 1999;12:245–250.
   PubMedGoogle Scholar
• Palatini P, Mormino P, Santonastoso M, Mos L, Dal Follo M, Zanata G, Pessina AC. Target-organ damage in stage 1 hypertensive subjects with white coat hypertension: Results from the HARVEST study. Hypertension 1998;31:57–63.
   PubMed Web of Science ®Google Scholar
• Hekimsoy Z, Payzin B, Ornek T, Kandogan G. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications 2004;18:173–176.
   PubMed Web of Science ®Google Scholar
• Brown AS, Hong Y, de Belder A, Beacon H, Beeso J, Sherwood R, Edmonds M, Martin JF, Erusalimsky JD. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:802–807.
   PubMed Web of Science ®Google Scholar
• Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med 1993;86:739–742.
   PubMedGoogle Scholar
• Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004;44:415–422.
   PubMed Web of Science ®Google Scholar
• Erhart S, Beer JH, Reinhart WH. Influence of aspirin on platelet count and volume in humans. Acta Haematol 1999;101:140–144.
   PubMed Web of Science ®Google Scholar
• Thompson CB, Jakubowski JA. The pathophysiology and clinical relevance of platelet heterogeneity. Blood 1988;72:1–8.
   PubMed Web of Science ®Google Scholar
• Giles C, Inglis TC. Thrombocytopenia and macrothrombo- cytosis in gestational hypertension. Br J Obstet Gynaecol 1981;88:1115–1119.
   PubMedGoogle Scholar
• Nadar SK, Lip GY, Blann AD. Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project. Thromb Haemost 2004;92:1342–1348.
   PubMed Web of Science ®Google Scholar
• Bath PM, Carney C, Markandu ND, MacGregor GA. Platelet volume is not increased in essential hypertension. J Hum Hypertens 1994;8:457–459.
   PubMed Web of Science ®Google Scholar
• Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: A 10-year follow-up study. Circulation 1998;98:1892–1897.
   PubMed Web of Science ®Google Scholar
• Wu KK. Platelet activation and carotid arterial atherothrom- bosis. In: Gotto AM, Lenfant C, Paoletti R, Catapano AL, Jackson AS, editors. Multiple risk factors in cardiovascular disease. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1998. pp 61–65.
   Google Scholar
• Kristensen SD. The platelet-vessel wall interaction in experi- mental atherosclerosis and ischaemic heart disease with special Reference to thrombopoiesis. Dan Med Bull 1992;39:110–127.
   PubMedGoogle Scholar
• van der Loo B, Martin JF. Megakaryocytes and platelets in vascular disease. Baillieres Clin Haematol 1997;10:109–123.
   PubMed Web of Science ®Google Scholar